NMDA receptor

From WikiMD's WELLNESSPEDIA

(Redirected from Glycine site)

L-Glutaminsäure - L-Glutamic acid
Glycine 2D skeletal
Neramexane
NMDA
Ketamine

NMDA receptor (N-methyl D-aspartate receptor), also known as NMDAR, is a type of glutamate receptor that is critical for controlling synaptic plasticity and memory function. The NMDA receptor is named after its agonist molecule, N-methyl-D-aspartate (NMDA).

Structure[edit]

The NMDA receptor is a heterotetramer composed of two GluN1 and two GluN2 subunits. The GluN1 subunit is essential for NMDA receptor function, while the GluN2 subunit is responsible for the receptor's functional diversity.

Function[edit]

NMDA receptors are notable for their voltage-dependent activation, requiring simultaneous binding of glutamate and glycine in conjunction with relief of voltage-dependent magnesium block. This property is fundamental for its role in synaptic plasticity.

Clinical significance[edit]

NMDA receptors are associated with a variety of neurological diseases and disorders, such as epilepsy, Alzheimer's, Parkinson's, and Huntington's.

Pharmacology[edit]

NMDA receptors have a very broad spectrum of ligands. The diversity of the ligands is because of the widespread distribution of the receptor in the central nervous system and its role in such varied phenomena as sensory perception, cognition, and memory, and its role in disease states such as stroke, epilepsy, and neurodegenerative diseases.

Gallery[edit]

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.